DHTIOTCServices-Help Supply ServicesUS GAAP · USD

Dalrada Technology Group, Inc.

Dalrada Technology Group, Inc. is a diversified operating company with businesses spanning healthcare, climate technology, precision manufacturing, and technology services. It develops and sells products and services such as specialty pharmacy offerings, heat pumps, construction-related climate solutions, precision parts, and software engineering and digital services through subsidiaries including Genefic, Dalrada Climate Technology, Dalrada Precision Manufacturing, and Dalrada Technologies.

Revenue20.3m USD
+2.3 %y/y
Operating profit (EBIT)-20.5m USD
+23.8 %y/y
EBIT margin-100.8%
+34.5 ppy/y
Net income-24.6m USD
+14.9 %y/y
Free cash flow-18.3m USD
−120.8 %y/y

Fiscal year 2025 · change from previous year

Development 2020–2025

-40-2002040m USD2020: 1.2 m USD2020: EBIT -2.7 m USD20202021: 3.4 m USD2021: EBIT -8.6 m USD20212022: 19 m USD2022: EBIT -10 m USD20222023: 30 m USD2023: EBIT -21 m USD20232024: 20 m USD2024: EBIT -27 m USD20242025: 20 m USD2025: EBIT -20 m USD202520-20
RevenueOperating profit (EBIT)

Business

Share of revenue
Healthcare and pharmacy services55 %

Genefic provides specialty pharmaceutical, screening, and wellness-related offerings.

Climate technology and construction35 %

Dalrada Climate Technology includes heat pumps, energy services, and construction-related work through Bothof.

Technology services7 %

Dalrada Technologies and Prakat provide software engineering, modernization, and digital services.

Precision manufacturing3 %

Dalrada Precision Manufacturing sells precision parts and related manufacturing solutions.

Products

Reported · share of revenue
58.6%33.6%FY2025100 %
  • Service Revenue Third Parties58.6 %
  • Product Sales Third Parties33.6 %
  • Service Revenue Related Party7.9 %

Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.

Customers

Dalrada sells to a mix of healthcare users, commercial and residential building customers, public-sector and private-sector construction clients, and enterprise technology customers. Its customer base is fragmented across subsidiaries, with demand driven by pharmacy needs, building decarbonization projects, software delivery contracts, and precision manufacturing orders.

Healthcare and pharmacy customers

Patients, providers, and healthcare channels buying specialty pharmacy, screening, and wellness offerings from Genefic.

Commercial climate and energy customers

Businesses and institutions buying heat pumps, ESG-oriented energy services, and related building solutions.

Construction and contracting clients

Residential, commercial, public, and private customers using Bothof Brothers for construction and design work.

Enterprise technology clients

Companies buying software engineering, testing, accessibility, modernization, and CRM-related services.

Precision manufacturing customers

Industrial customers purchasing precision parts and deposition technology products.

Strategy

Dalrada’s stated strategy is to improve profitability by focusing on subsidiaries expected to be most profitable, reducing investment in lower-return areas, and pursuing synergistic opportunities across the portfolio. Near term, management is also trying to commercialize heat pumps, expand pharmacy operations, grow Bothof Brothers’ footprint, and support the business with external financing.

Improve portfolio profitabilityShort term

The company is under going-concern pressure and needs to concentrate resources on businesses with better margin potential.

Commercialize climate technology productsShort term

Heat pump adoption could create a higher-margin growth engine and validate the DCT platform.

Expand operating scale in healthcare and constructionMedium term

Management is trying to broaden revenue sources and improve operating leverage across subsidiaries.

Geography

Q3/2025

Dalrada operates primarily in the United States, with technology and climate-related activities also extending into Europe through Dalrada Technology Spain. The reports also describe global customer relationships for the technology business, while construction and contracting revenue is concentrated throughout the United States. Geography matters because the company’s mix of U.S. healthcare, domestic construction, and international technology exposure creates different regulatory, execution, and demand risks.

United States88 %
India6.7 %
Spain3.6 %
United Kingdom1.9 %

Share of the revenue the company reports by geography.

Risks

Dalrada faces substantial going-concern and liquidity risk because it continues to report significant losses and depends on outside financing and related-party support. Its multi-division structure also creates execution risk, since performance varies sharply across healthcare, construction, manufacturing, and technology, while customer concentration and contract completion can materially swing results.

Sorted by severity
Going-concern uncertaintyCritical

The company reports substantial losses and limited working capital, raising doubt about its ability to continue without new funding.

Exposure: All operations

Financing dependence and dilutionHigh

Operations are being funded through equity sales, debt, and related-party support, which may not be available on favorable terms.

Exposure: Corporate liquidity

Customer concentrationHigh

Precision manufacturing revenue fell after losing its primary customer, showing how dependent some units are on a small number of buyers.

Exposure: Dalrada Precision Manufacturing

Project and contract execution riskMedium

Construction and technology services depend on completing contracts and winning new work, which can cause revenue volatility.

Exposure: Dalrada Climate Technology and Dalrada Technologies

Commercial adoption risk for new productsMedium

Heat pump commercialization and federal/commercial adoption are still developing, so demand may take longer than expected.

Exposure: Dalrada Climate Technology

Accounting

Judgemental items
ASC 606 revenue recognition

The company recognizes revenue across goods and services, so timing depends on contract terms and performance obligations.

Impact: Can shift revenue between periods for pharmacy, construction, technology, and manufacturing activities

Going-concern and asset recoverability

Management states there is substantial doubt about continuing as a going concern, which raises questions about asset values and future obligations.

Impact: May affect classification and recoverability of recorded assets and liabilities

Stock-based compensation

The company records equity-based compensation under ASC 718, which affects operating expenses and dilution.

Impact: Can increase reported losses and share count

Related-party financing

The company relies on related-party notes and support for liquidity, which affects financing cash flows and debt presentation.

Impact: Important for assessing true funding needs and leverage

Publicly listed companies with a comparable business focus.

Last updated: 28/04/2026

Dalrada Technology Group, Inc. (OTC) – Services-Help Supply Services | Financial Analysis – Clarifo